Terapet SA,, a CERN spin-off in MedTech, was incorporated in Geneva, Switzerland on 19.12.2019. The founders are two CERN physicists, Dr. Christina Vallgren (PhD in Applied Physics, MSc in Nuclear Physics and MBA), Dr. Marcus Palm (PhD in Applied Physics, MSc in Engineering Physics and Electronics) and a leading radiation oncologist, Prof. Raymond Miralbell (Radiation Oncologist 40+ years). Terapets core technology is an innovative platform technology for imaging in nuclear medicine and radiotherapy. On June 13, 2025, Terapet SA successfully achieved ISO 13485:2016 certificationa major milestone that underscores the companys commitment to innovation, quality, regulatory compliance, and, ultimately, improved patient care.

News

12.03.2024 European funds to propel Swiss projects (startupticker.ch)
12.05.2021 Finalists of the W. A de Vigier revealed (startupticker.ch)
31.08.2020 Terapet remporte CHF 150 000 de Venture Kick (startupticker.ch)

Videos and Presentations


Terapet: a Geneva based CERN MedTech spin-off


Invited panelist at the Innosuisse Stakeholder Event on 22.11.2022


TERAPET: Improving Proton Therapy for Cancer Treatments


Elevator Pitch by our CTO, Marcus Palm. TERAPET was among Top10 at Swiss Innovation Challenge 2019